SYNABS SA

SynAbs sa, Belgium, is a CRO providing custom antibody services as well as a catalog of 150+ references, mainly control & secondary monoclonal antibodies, to the R&D and In Vitro Diagnostic market.

Thanks to its 7 scientists, as well as the broad biotechnology support offered by its sister companies Rd-Biotech and Diaclone, France, SynAbs can present a one-stop-shop portfolio of services, covering the antigen synthesis and the hapten-carriers chemistry, through the parallel immunisation of mice, rats and guinea pigs, up to the custom generation and manufacturing of gram levels of these mouse, rat and guinea pigs monoclonal antibodies.

This unique triple immunisation platform enables SynAbs to increase the probability getting the unique monoclonal our clients are looking for, and therefore maximizes the success rate of our projects.

SynAbs has currently 130 m2 of production laboratories and expects to generate earnings of 1 million euro in the short term.